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Abstract. Twenty-six trihaloacetylazulene derivatives were
investigated for their tumor-specific cytotoxicity and apoptosis-
inducing activity against three human normal cells (HGF, 
HPC, HPLF) and four human tumor cell lines (HSC-2, HSC-3,
HSC-4, HL-60). The trichloroacetylazulenes [1b-13b] generally
showed higher cytotoxicity as compared to the corresponding
trifluoroacetylazulenes [1a-13a]. The trichloroacetylazulenes
[1b-13b] also showed higher tumor-specific cytotoxicity (expressed
as TS value) than the corresponding trifluoroacetylazulenes 
[1a-13a]. Especially, 2,3-dimethyl-1-trichloroacetylazulene [5b]
and 1,3-ditrichloroacetyl-4,6,8-trimethylazulene [11b] showed the
highest cytotoxicity and tumor specificity (TS >35.6 and >44.1,
respectively). These compounds induced internucleosomal DNA
fragmentation in HL-60 cells, but not in HSC-2 and HSC-3 cells,
but activated caspase-3, -8 and -9 in all of these cells, suggesting
the activation of both mitochondria-independent (extrinsic) and -
dependent (intrinsic) pathways. Western blot analysis showed that
two compounds [5b, 11b] slightly increased the intracellular
concentration of pro-apoptotic proteins (Bad, Bax) in HSC-2
cells. None of the 26 compounds showed anti-HIV activity. These
results suggest [5b] and [11b] as possible candidates for future
cancer chemotherapy. 
Azulene (1-4), an isomer of naphthalene, has a dipole
moment and a resonance energy with intermediate values
between those of benzene and naphthalene and is
considerably more reactive, when compared with two
arenes. Azulene derivatives have been investigated for their
synthesis and chemical reactions (5-7). Their derivatives
have shown several biological activities, including
antibacterial activity (8), anti-ulcer activity (9), relaxant
activity (10), inhibition of thromboxane A2-induced
vasoconstriction and thrombosis (11), acute toxicity and
local anesthetic activity (12) and chemotherapeutic activity
against mucous membrane diseases (13, 14). However, the
effects of azulene derivatives on cellular function have not
yet been investigated in detail.
We have recently initiated the study of the structure-
activity relationship of a total of 81 azulene (15, 16),
tropolone (17, 18) and azulenequinone (19, 20) derivatives.
1,3-Difluoroazulene (15), 2,4-dibromo-7-methoxytropone
(17), 3-morpholino-1,5-azulenequinone and 3,7-dibromo-
1,5-azulenequinone (19) were found to inhibit the NO
production by activated mouse macrophages, without (15)
or with (17, 19) the inhibition of iNOS mRNA and protein
expression. In addition, 2-acetylaminoazulene, diethyl 
2-chloroazulene-1,3-dicarboxylate and methyl 7-isopropyl-2-
methoxyazulene-1-carboxylate showed higher tumor-specific
cytotoxicity than the parent compounds, such as azulene and
guaiazulene (16). Tropolone derivatives with a phenolic OH
group, hinokithiol, its tosylate and methyl ethers showed
relatively higher tumor-specific cytotoxic activity (18). 3-(3-
Guaiazulenyl)-1,5-azulenequinone and 7-isopropyl-3-(4-
methylanilino)-2-methyl-1,5-azulenequinone showed
relatively higher tumor-specific cytotoxicity and induced
apoptosis in human tumor cell lines, possibly via the
activation of both mitochondria-independent (extrinsic) and
-dependent (intrinsic) pathways (20). 
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Hexafluorotrihydroxyvitamin D3 derivatives have shown
higher differentiation-inducing activity (21, 22) than the
parent compound, suggesting that the introduction of fluoride
may have enhanced the biological activity of vitamin D3.
However, it is not clear whether the introduction of halogens
other than fluoride show a similar enhancing effect. Whether
trifluoroacetylazulenes [1a-13a] and trichloroacetylazulenes
[1b-13b] display tumor-specific cytotoxic activity was
investigated using three normal human cells [gingival
fibroblast (HGF), pulp cell (HPC), periodontal ligament
fibroblast (HPLF)] and four human tumor cell lines [oral
squamous cell carcinoma (HSC-2, HSC-3, HSC-4),
promyelocytic leukemia (HL-60)]. Whether such compounds
induce apoptosis-associated characteristics (such as DNA
fragmentation, caspase activation and apoptosis-related
protein expression) in human tumor cells was also examined.
Materials and Methods
Materials. The following chemicals and reagents were obtained
from the indicated companies: Dulbecco’s modified Eagle medium
(DMEM), RPMI 1640 (Gibco BRL, Grand Island, NY, USA);
fetal bovine serum (FBS) (JRH, Bioscience, Lenexa, KS, USA),
dimethyl sulfoxide (DMSO) (Wako Pure Chem, Ind., Ltd., Osaka,
Japan); 3-(4,5-dimethylthiazol-2-yl)-2,2-diphenyltetrazolium
bromide (MTT), 3’-azido-2’, 3’-dideoxythymidine (AZT),
dideoxycytidine (ddC) (Sigma Chem Co., St. Louis, MO, USA).
Synthesis of trihaloacetylazulenes. The trihaloacetylazulene derivatives
were synthesized according to the published methods for the
following compounds: 1-trifluoroacetylazulene [1a] (23,24), 3-methyl-
1-trifluoroacetylazulene [2a] (25), 3-ethyl-1-trifluoroacetylazulene
[3a] (24-26), 2-methyl-1-trifluoroacetylazulene [4a] (25), 2,3-
dimethyl-1-trifluoroacetylazulene [5a] (24-26), 7-isopropyl-3-methyl-
1-trifluoroacetylazulene [6a] (24-26), 3-ethyl-7-isopropyl-1-
trifluoroacetylazulene [7a] (24-26), 3-trifluoroacetylguaiazulene
[8a] (26, 27), 6-isopropyl-2-methyl-1-trifluoroacetylazulene [9a]
(24-26), 1-trifluoroacetyl-4,6,8-trimethylazulene [10a] (26, 27), 
1,3-ditrifluoroacetyl-4, 6,8-trimethylazulene [11a] (28-30), 1,3-
ditrifluoro acetylazulene [12a] (28-30), 2-methyl-1,3-ditrifluoro-
acetylazulene [13a] (28-30), 1-trichloroacetylazulene [1b] (24), 3-
methyl-1-trichloroacetylazulene [2b] (24-26), 3-ethyl-1-trichloro-
acetylazulene [3b] (24-26), 2-methyl-1-trichloroacetylazulene [4b]
(24-26), 2,3-dimethyl-1-trichloroacetylazulene [5b] (24-26), 
7-isopropyl-3-methyl-1-trichloroacetylazulene [6b] (24-26), 3-ethyl-7-
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Figure 1. Structures of 13 trifluoroacetylazulenes [1a-13a] and 13 trichloroacetylazulenes [1b-13b]. 
isopropyl-1-trichloroacetylazulene [7b] (24-26), 3-trichloroacetyl-
guaiazulene [8b] (26), 6-isopropyl-2-methyl-1-trichloroacetylazulene
[9b] (24-26), 1-trichloroacetyl-4,6,8-trimethylazulene [10b] (26), 1,3-
ditrichloroacetyl-4,6,8-trimethylazulene [11b] (28-30), 1,3-ditrichloro-
acetylazulene [12b] (28-30) and 2-methyl-1,3-ditrichloroacetylazulene
[13b] (28-30).
Cell culture. Three human oral tumor cell lines (HSC-2, HSC-3,
HSC-4) and three human normal cells [HGF (5-8 population
doubling level (PDL)), HPC (5-8PDL), HPLF (5-8PDL)] were
cultured in DMEM supplemented with 10% heat-inactivated FBS.
Human promyelocytic leukemic HL-60 cells were cultured in
RPMI 1640 supplemented with 10% heat-inactivated FBS. The
tumor cell lines were obtained from the Riken Cell Bank. Normal
cells were prepared from periodontal tissues, according to the
guidelines of Meikai University Ethics Committee (No. 0206), after
obtaining informed consent from the patients.
Assay for cytotoxic activity. The cells (other than HL-60 cells) were
inoculated at 5x103 cells/well in 96-microwell plates (Becton
Dickinson Labware, NJ, USA), unless otherwise stated. After 24 h,
the medium was removed by suction with an aspirator and replaced
with 0.1 mL of fresh medium containing various concentrations of
the test compounds. The first well contained 200 ÌM sample which
was diluted two-fold sequentially, with three replicate wells for
each concentration. The cells were incubated for another 24 h and
the relative viable cell number was then determined by the MTT
method. In brief, fresh culture medium containing 0.2 mg/mL MTT
was added to the cells which were then incubated for another 4 h.
The cells were lysed with 0.1 mL of DMSO and the absorbance of
the cell lysate at 540 nm was determined using a microplate reader
(Biochromatic Labsystem, Helsinki, Finland) (16, 18, 20). The A540
of the control cells were usually in the range from 0.40 to 0.90. 
The HL-60 cells were inoculated at 7x104/0.1 mL in 
96-microwell plates to which were added various concentrations of
the test compounds. After incubation for 24 h, the viable cell number
was determined by trypan blue exclusion under a light microscope. 
The 50% cytotoxic concentration (CC50) was determined from
the dose-response curve. Tumor specificity (TS) was determined by
the following equation: TS={[CC50 (HGF) + CC50 (HPC) + CC50
(HPLF)] / [CC50 (HSC-2) + CC50 (HSC-3) + CC50 (HSC-4) +
CC50 (HL-60)]} x (4/3)
Assay for DNA fragmentation. The cells were washed once with 
PBS (-) and lysed with 50 ÌL lysate buffer [50 mM Tris-HCl (pH 7.8),
10 mM EDTA, 0.5% (w/v) sodium N-lauroylsarcosinate solution].
The solution was incubated with 0.4 mg/mL RNase A and 0.8 mg/mL
proteinase K for 1-2 h at 50ÆC, and then mixed with 50 ÌL NaI
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Table I. Cytotoxic activity of trihaloacetylazulenes.
Cytotoxic activity (CC50:ÌM)
Normal human cells Human tumor cell lines
Compd. MW TS
HGF HPLF HPC HSC-2 HSC-3 HSC-4 HL-60
[1a] 224 159.8 161.9 >191.7 92.5 106.3 129.7 59.6 >1.7
[2a] 238 >179.7 >198.0 >200.0 125.2 >187.7 172.0 59.5 ><1.4
[3a] 252 >200.0 >191.6 >200.0 170.8 >178.0 >200.0 62.0 ><1.3
[4a] 238 177.0 120.9 >187.9 69.9 101.6 79.8 43.3 >2.2
[5a] 252 >200.0 >200.0 >200.0 >200.0 153.5 >176.5 31.7 ><1.7
[6a] 280 >200.0 >200.0 >200.0 >200.0 >161.0 >146.4 31.8 ><1.8
[7a] 294 >200.0 >200.0 >200.0 180.5 142.1 137.7 54.9 >1.8
[8a] 294 >200.0 >200.0 >200.0 >200.0 128.0 >135.7 69.9 ><1.8
[9a] 280 >200.0 >200.0 >200.0 >200.0 >174.9 >197.2 40.6 ><1.5
[10a] 266 >200.0 >200.0 >200.0 >200.0 >200.0 >200.0 27.5 ><1.4
[11a] 362 >200.0 >200.0 >200.0 >200.0 140.2 >200.0 20.4 ><1.7
[12a] 320 >200.0 199.0 >200.0 168.2 139.6 68.5 198.1 >1.5
[13a] 334 165.3 190.3 >200.0 151.2 167.2 130.6 38.6 >1.7
[1b] 273.5 159.3 95.1 98.6 36.5 40.4 34.0 16.5 3.9
[2b] 287.5 >167.9 >200.0 >200.0 106.4 133.7 103.5 5.4 >2.3
[3b] 301.5 >200.0 >200.0 >200.0 140.5 115.5 >200.0 26.4 ><1.8
[4b] 287.5 <107.7 152.6 138.7 3.6 36.5 3.9 1.6 <9.5
[5b] 301.5 158.4 115.8 108.6 <1.6 7.3 1.8 1.6 >35.6
[6b] 329.5 >200.0 >200.0 >200.0 >131.9 65.3 >123.2 7.6 ><3.1
[7b] 343.5 199.5 >200.0 >200.0 120.0 65.0 68.0 18.8 >3.9
[8b] 343.5 47.1 19.6 36.6 8.4 6.5 10.7 9.7 3.8
[9b] 329.5 96.4 104.4 169.8 23.4 34.9 29.3 14.8 4.7
[10b] 315.5 >200.0 >192.3 >200.0 27.3 9.2 16.0 4.9 >19.6
[11b] 461 153.2 >172.9 >200.0 29.0 <6.1 3.5 2.3 >44.1
[12b] 419 >200.0 >199.7 >200.0 57.5 92.1 52.9 13.1 >3.8
[13b] 433 160.7 176.7 177.0 52.4 8.9 40.7 1.9 10.0
TS: tumor-specific cytotoxicity. Each value represents the mean from three to four independent experiments.
solution [7.6 M NaI, 20 mM EDTA-2Na, 40 mM Tris-HCl, pH 8.0],
followed by 250 ÌL of ethanol. After centrifugation for 20 min at
20,000 xg, the precipitate was washed with 1 mL of 70% ethanol and
dissolved in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). The
sample (10-20 ÌL) was applied to 2% agarose gel electrophoresis in
TBE buffer (89 mM Tris-HCl, 89 mM boric acid, 2 mM EDTA, pH
8.0). The DNA molecular marker (Bayou Biolabs, Harahan, LA,
USA) and DNA from apoptotic HL-60 cells, induced by UV
irradiation, were run in parallel (16, 18, 20). After staining with
ethidium bromide, DNA was visualized by UV irradiation and
photographed with a CCD camera (Bio Doc Inc., UVP).
Assay for caspase activation. The cells were washed with PBS and
lysed in the lysis solution (MBL, Nagoya, Japan). After standing for
10 min on ice followed by centrifugation for 5 min at 10,000 xg, the
supernatant was collected. The lysate (50 ÌL, equivalent to 200 Ìg
protein) was mixed with 50 ÌL 2x reaction buffer (MBL) containing
substrates for caspase 3 (DEVD-pNA (p-nitroanilide)), caspase 8
(IETD-pNA) or caspase 9 (LEHD-pNA). After incubation for 2 h
at 37ÆC, the absorbance at 405 nm of the liberated chromophore
pNA was measured by a plate reader (16, 18, 20). 
Western blotting. The cells were lysed with 100 ÌL of lysis buffer 
(10 mM Tris-HCl, pH 7.6, 1% Triton X-100, 150 mM NaCl, 5 mM
EDTA and 2 mM PMSF) for 10 min in ice water and were then
incubated for 50 min at 4ÆC with RT-5 ROTATOR (Titec, Saitama,
Japan). The cell lysates were centrifuged at 16,000 xg for 20 min at
4ÆC to remove insoluble materials and the supernatant was collected.
The protein concentration of the supernatant was determined by a
Protein Assay Kit (Bio Rad, Hercules, CA, USA). The cell lysates
(containing 15 Ìg protein) were mixed with 2 x sodium dodecyl
sulfate (SDS)-sample buffer (0.1 M Tris-HCl, pH 6.8, 20% glycerol,
4% SDS, 0.01% bromophenol blue, 1.2% 2-mercaptoethanol), boiled
for 10 min, applied to SDS-12% polyacrylamide gel electrophoresis
and were then transferred to the polyvinylidene difluoride (PVDF)
membrane. The membranes were blocked with 5% skim milk in PBS
plus 0.05% Tween 20 overnight at 4ÆC and incubated with anti-Bcl-
2 antibody (1:1,000), anti-Bax antibody (1:1,000), or anti-actin
antibody (1:1,000) (Santa Cruz Biotechnology, Delaware, CA, USA)
for 90 min at room temperature and were then incubated with
horseradish peroxidase-conjugated anti-rabbit IgG for 1 h at room
temperature. Immunoblots were developed by Western Lightningì
Chemiluminescence Reagent Plus (Perkin Elmer Life Sciences,
Boston, MA, USA) and were analyzed on a Macintosh (Power
Macintosh 7600/120) computer, using the public domain NIH Image
Program (16, 18, 20).
Results
Structure and activity relationship. The trifluoroacetylazulenes
[1a-13a] showed lower cytotoxicity compared to the
trichloroacetylazulenes [1b-13b] (Table I). The relative
cytotoxicity of 13 trifluoroacetylazulenes was comparable
with that of the corresponding trichloroacetylazulenes.
Especially trifluoroacetylazulenes [5a, 6a, 8a, 9a, 10a, 11a]
showed much lower cytotoxic activity, whereas 3-trichloro-
acetylguaiazulene [8b] and 6-isopropyl-2-methyl-1-trichloro-
acetylazulene [9b] showed higher cytotoxicity for both
normal and tumor cells. In general, the trichloro-
acetylazulenes showed higher cytotoxicity than tropolone
(18) and the azulenequinones (20). The trifluoro-
acetylazulenes generally showed lower cytotoxic activity than
the corresponding azulenes (16). 2,3-Dimethyl-1-trichloro-
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Figure 2. Induction of DNA fragmentation by two trichloroacetylazulenes.
Near confluent HL-60, HSC-2 or HSC-3 cells were incubated for 6 h with
the indicated concentrations of 2,3-dimethyl-1-trichloroacetylazulene [5b],
1,3-ditrichloroacetyl-4,6,8-trimethylazulene [11b] or 1 Ìg/mL actinomycin
D (Act-D) (positive control). DNA was then extracted and applied to
agarose gel electrophoresis. Marker DNA was run in lane 11.
Representative data from three independent experiments are shown.
acetylazulene [5b] and 1,3-ditrichloroacetyl-4,6,8-tri-
methylazulene [11b] more efficiently killed the tumor cell
lines than normal cells, yielding the highest tumor-specific
cytotoxicity indices (TS) of >35.6 and >44.1, respectively. 
2-Methyl-1-trichloroacetylazulene [4b] (TS>9.5), 1-trichloro-
acetyl-4,6,8-trimethylazulene [10b] (TS>19.6) and 2-methyl-
1,3-ditrifluoroacetylazulene [13b] (TS=10.0) showed slightly
lower, but still high TS values.
Apoptosis induction. 2,3-Dimethyl-1-trichloroacetylazulene
[5b] (higher than 1.6 ÌM) and 1,3-ditrichloroacetyl-4,6,8-
trimethylazulene [11b] (higher than 2.3 ÌM) induced
internucleosomal DNA fragmentation in HL-60 cells. Their
effects reached maximal levels at 4.8 and 6.9 ÌM, respectively
(Figure 2). They did not induce internucleosomal DNA
fragmentation, but induced the production of large DNA
fragments in the HSC-2 and HSC-3 cells (center and lower
panels, Figure 2). Compound [5b] produced a smear pattern
of DNA fragmentation, showing slightly higher DNA
fragmentation activity than that of [11b].
Compounds [5b and 11b] activated caspase-3, -8 and -9
in all of these cells (Figure 3), suggesting the activation of
both mitochondria-independent (extrinsic) and -dependent
(intrinsic) pathways. The apoptosis-inducing activity of [5a]
was slightly higher than that of [11b]. 
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Figure 3. Activation of caspases-3, -8 and -9 by 2 trichloroacetylazulenes.
HL-60 (upper panel), HSC-2 (center panel) and HSC-3 (lower panel) cells
were incubated for 4 h without (control) or with the indicated
concentrations of 2,3-dimethyl-1-trichloroacetylazulene [5b] or 1,3-ditrichlo-
roacetyl-4,6,8-trimethylazulene [11b] or 1 Ìg/mL actinomycin D (Act-D)
(positive control). The absorbance at 405 nm (the relative amount of the
pNA released from the substrate for caspase-3, -8 and -9) in control,
untreated cells was 0.047, 0.029, 0.014 (HL-60), 0.0085, 0.0055, 0.0040
(HSC-2) and 0.015, 0.018, 0.0105 (HSC-3), respectively. Each point
represents mean±S.D. from 3~4 independent experiments.
Figure 4. Effect of two trichloroacetylazulenes on the intracellular
concentrations of apoptosis-related proteins. HL-60 cells were incubated
for the indicated times without (control) or with 1.6 ÌM 2,3-dimethyl-1-
trichloroacetylazulene [5b], 2.3 ÌM 1,3-ditrichloroacetyl-4,6,8-
trimethylazulene [11b]. The cell lysate (equivalent to 15 Ìg/mL) was
subjected to Western blot analysis with respective antibodies. The
intracellular concentration of Bax and Bcl-2 was quantified and expressed
as the ratio to that of Actin and the control level of these proteins was
normalized to 1.0. Each value represents mean±S.D. from three to four
independent experiments.
Western blot analysis showed that [5b and 11b] did not
significantly change the intracellular concentration of either
pro-apoptotic (Bax) or anti-apoptotic (Bcl-2) proteins
during the apoptosis induction of HL-60 cells (Figure 4). 
Discussion
The results of the present study demonstrated that all 13
trichloroacetylazulenes showed higher cytotoxic activity
against tumor cell lines than the corresponding
trifluoroacetylazulenes. Whether the chlorination of other
antitumor compounds results in a similar enhancement of
cytotoxic activity remains to be investigated. Among the 26
trihaloacetylazulenes, 2,3-dimethyl-1-trichloroacetylazulene
[5b] and 1,3-ditrichloroacetyl-4,6,8-trimethylazulene [11b]
showed the highest tumor-specific cytotoxic activity
(TS=>35.6, >44.1). This value is relatively high, since a
total of 350 compounds including flavones, flavonols 
(3-hydroxyflavones) and isoprenoid-substituted flavonoids,
benzophenones, xanthones, anthraquinones, phenylbutanone
glucoside, stilbene glucoside, isoflavones, isoflavanones,
stilbenes (TS=0.3-31.7), coumarin derivatives (TS=1.0->11.0),
procyanidines and flavonoids (TS=1.0->7.4), hydrolysable
tannins (TS=1.0-8.2), triterpene aglycones and glycosides
(TS=0.65->2.8), cycloartane glycosides and chromones
(TS=0.7-1.4), furostaol glycosides (TS=0.4->17.0), 
·,‚-unsaturated ketones (TS=0.6-1.9), hydroxyketones
(TS=1.0->17.6), ‚-diketones (TS=0.3-6.3), stylrylchromones
(TS=1.4-27.3), dihydroisoxazole and isoxazole derivatives
(TS=0.9-1.6) showed lower tumor-specificity (31). We have
recently reported that apoptosis-inducing agents 
(‚-diketones (32), ·,‚-unsaturated ketones (33),
hydroxylketones (34)) do not always show tumor-specific
cytotoxicity and compounds with higher tumor specificity do
not always induce apoptosis. Compounds [5b and 11b] are
unique in the sense that they have both higher tumor
specificity and apoptosis-inducing activity.
It was found that [5b and 11b] induced DNA
fragmentation and activated both the mitochondria-
independent extrinsic pathway (involved with caspase-8) and
the mitochondria-dependent intrinsic pathway (involved
with caspase-9) (35). It was unexpected that these
compounds would induce little or no detectable change in
the expressions of Bax and Bcl-2 proteins, since the pro-
apoptotic Bax protein is usually up-regulated, whereas the
anti-apoptotic Bcl-2 protein is down-regulated during
apoptosis (35). The ratio of Bax/Bcl-2 determines the fate
of cells, either directing them to survival or death.
Additional study is required to explain these unexpected
findings regarding the Bax and Bcl-2 expressions and to
elucidate the killing mechanism.
We have investigated various biological activities of
trihaloacetylazulenes [1a-13a, 1b-13b] and found that none
of these compounds showed anti-HIV activity (SI<1), in
contrast to the potent anti-HIV activity of AZT (SI=6367)
and ddC (SI=808), positive control (data not shown).
Although the higher tumor specificity and apoptosis-inducing
activity of [5b and 11b] have been demonstrated, in vivo
studies are required to evaluate their antitumor potential.
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